Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms
Conditions
Interventions
Intervention1: T. TAPENTADOL 50mg: Dose : 50mg, per oral, stat dose, to be given 1 hour postoperatively with sips of water. Patient will be monitored for symptoms of CRBD for 24 hours from the time me
Sponsors
Sri Ramachandra Institute of Higher Education and Research
Eligibility
Inclusion criteria
Inclusion criteria: Male Age 18 to 80 years ASA I , II , III Undergoing Elective Transurethral resection of Prostate under Regional anaesthesia Requiring bladder catheterization
Exclusion criteria
Exclusion criteria: ASA IV patients Contraindication for spinal anaesthesia Significant cardiac disease Chronic analgesic use High AV Block Psychiatric disease Renal failure Paralytic ileus History of urinary tract obstruction/neurogenic/ overactive bladder Acute exacerbation of Bronchial Asthma
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the incidence of postoperative Catheter Related Bladder Discomfort.Timepoint: 0 minutes 30 minutes 1st hour 2nd hour 4th hour 8th hour 12th hour 24th hour | — |
Secondary
| Measure | Time frame |
|---|---|
| Need for additional analgesic. Assess any adverse effects including postoperative nausea and vomiting, respiratory depression, sedation, drowsiness, confusion and dry mouth.Timepoint: 0 minutes 30 minutes 1st hour 2nd hour 4th hour 8th hour 12th hour 24th hour | — |
Countries
India
Contacts
Public ContactS Ishwarya
Sri Ramachandra Institute Of Higher Education and Research
Outcome results
None listed